Archive for November 2020

We see an uptake in Remote, Decentralized and Hybrid Trials. Do you?

We are soon leaving a very difficult year in all aspects. We lived with global pandemic and civil troubles in the news all year long. However, our Scientific Lead, Bernard Vrijens sees an uptake in remote, decentralized, and hybrid trials. Because humans will always learn, and innovate from difficulties. That’s exactly what PharmaVoice magazine tried…

Read More